Given the role IL-1β plays in perpetuating chronic inflammation in metabolic disorders and that circadian disruption further enhances susceptibility to these disorders (75), our findings may identify BMAL1 as a critical regulator of this glucose metabolism-inflammation feedback loop. This evidence concerns the gene IL1B and Other metabolic disease.